Literature DB >> 7357301

Hydrallazine-induced cutaneous vasculitis.

R M Bernstein, J Egerton-Vernon, J Webster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7357301      PMCID： PMC1600356          DOI： 10.1136/bmj.280.6208.156-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

Review 1.  Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Authors:  H M Perry
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

2.  Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

Authors:  I Strandberg; G Boman; L Hassler; F Sjöqvist
Journal:  Acta Med Scand       Date:  1976
  2 in total
  12 in total

Review 1.  Drug-induced lupus erythematosus: incidence, management and prevention.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.

Authors:  R A Asherson; A G Benbow; C J Speirs; N Jackson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

3.  A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.

Authors:  Maria Catalina Espinosa; Belicia Ding; Kati Choi; Daniel N Cohen; Marco Marcelli; Onome Whiteru Ifoeze
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-03-27

4.  Hydralazine-induced necrotising vasculitis.

Authors:  A Peacock; D Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

5.  Cutaneous manifestations of hydrallazine toxicity.

Authors:  A P Brooks; J W Paulley
Journal:  Br Med J       Date:  1980-02-16

6.  Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.

Authors:  L Nässberger; A G Sjöholm; H Jonsson; G Sturfelt; A Akesson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.

Authors:  Vamsee Priya Marina; Deepak Malhotra; Dinkar Kaw
Journal:  Int Urol Nephrol       Date:  2011-05-17       Impact factor: 2.370

8.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment.

Authors:  H A Cameron; L E Ramsay
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

9.  Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.

Authors:  R N Hobbs; A L Clayton; R M Bernstein
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

10.  Outcomes of hydralazine induced renal vasculitis.

Authors:  Homa Timlin; Jason E Liebowitz; Khusleen Jaggi; Duvuru Geetha
Journal:  Eur J Rheumatol       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.